<DOC>
	<DOCNO>NCT00819754</DOCNO>
	<brief_summary>Triplets irinotecan , oxaliplatin infusional 5-fluorouracil ( FU ) /leucovorin ( LV ) associate high response rate long survival first-line treatment metastatic colorectal cancer ( mCRC ) . The oral fluoropyrimidine , capecitabine , well tolerate show well response rate 5-FU/LV metastatic colorectal cancer . A phase I dose-escalation study establish dose limit toxicity ( DLT ) , maximum tolerate dose ( MTD ) recommend phase II dose ( RPIID ) irinotecan , oxaliplatin capecitabine . This phase I /II study determine dose-limiting toxicity ( DLTs ) , maximum tolerate dose ( MTD ) , phase II recommend dose ( RD ) IXO bevacizumab combination safety RD expand cohort .</brief_summary>
	<brief_title>A Phase I/II Study IXO With Bevacizumab Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Histologically document adenocarcinoma colon rectum . Advanced and/or metastatic disease , incurable standard therapy . Unresectable advanced and/or metastatic unidimensionally measurable disease ( RECIST scale ) . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 2 Age : 18 year . Adequate haematological , renal hepatic function Patient consent must obtain accord local REB requirement . Patients must accessible treatment follow . Previous concurrent malignancy Pregnant lactate woman . Women childbearing potential must negative pregnancy test within 7 day prior registration . Concurrent treatment experimental drug anticancer therapy . Previous chemotherapy advance and/or metastatic disease . Previous adjuvant therapy irinotecan oxaliplatin . Previous full dose curative pelvic radiation therapy . Patients document brain metastasis . Serious illness medical condition . Gilbert 's disease Use enzyme induce anticonvulsant phenytoin , phenobarbital carbamazepine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>